HealthNetherlandsJul 28, 2026

Xeltis raises $22 (Netherlands, Jul 2026)

$22
€20.5 million
Browse investors in Netherlands →
Generated social card
Xeltis social card
Headline

Dutch-US MedTech Xeltis raises €20.5 million to advance artificial vessels and valves replaced by patients’ own tissue - EU-Startups

About

Xeltis is a commercial-stage MedTech company developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue. The company aims to improve patient outcomes in hemodialysis vascular access and cardiovascular replacements, addressing significant unmet needs in these areas.

Article summary

Dutch-US MedTech Xeltis raises €20.5 million to advance artificial vessels and valves replaced by patients’ own tissue  EU-Startups

Founder
Eliane Schutte
Eliane Schutte
Chief Executive Officer
Investors · 6
4 hidden
Horizon 3 HealthcareLead
FUND
European Innovation Council
FUND
Sign up free · see all 6 investors
Related rounds
Aug 04, 2026Ore Energy$43.0MSeries ANetherlands
Aug 01, 2026Keiron Printing Technologies$22.0MSeries ANetherlands
Jul 15, 2026Monumental$32.0MSeries BNetherlands
Jul 15, 2026Nopan$7.6M—Netherlands

About the investors in Netherlands

Investors in Netherlands

Explore funding data